Lactobacillus rhamnosus GG versus Placebo for Acute Gastroenteritis in Children | Zendy

David Schnadower | Zendy; Phillip I. Tarr | Zendy; T. Charles Casper | Zendy; Marc H. Gorelick | Zendy; J. Michael Dean | Zendy; Karen J. O’Connell | Zendy; Prashant Mahajan | Zendy; Adam C. Levine | Zendy; Seema Bhatt | Zendy; Cindy G. Roskind | Zendy; Elizabeth C. Powell | Zendy; Alexander J. Rogers | Zendy; Cheryl Vance | Zendy; Robert E. Sapién | Zendy; Cody S. Olsen | Zendy; Melissa Metheney | Zendy; Viani Dickey | Zendy; Carla Hall-Moore | Zendy; Stephen B. Freedman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Lactobacillus rhamnosus GG versus Placebo for Acute Gastroenteritis in Children

Author(s) -

David Schnadower,

Phillip I. Tarr,

T. Charles Casper,

Marc H. Gorelick,

J. Michael Dean,

Karen J. O’Connell,

Prashant Mahajan,

Adam C. Levine,

Seema Bhatt,

Cindy G. Roskind,

Elizabeth C. Powell,

Alexander J. Rogers,

Cheryl Vance,

Robert E. Sapién,

Cody S. Olsen,

Melissa Metheney,

Viani Dickey,

Carla Hall-Moore,

Stephen B. Freedman

Publication year - 2018

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1802598

Subject(s) - lactobacillus rhamnosus , acute gastroenteritis , placebo , medicine , microbiology and biotechnology , probiotic , gastroenterology , virology , biology , bacteria , pathology , genetics , alternative medicine

Acute gastroenteritis develops in millions of children in the United States every year, and treatment with probiotics is common. However, data to support the use of probiotics in this population are limited.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research